Skip to main content

Lutenca precursor IN solution

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION

Contents of the leaflet

  1. Introduction
  2. What is Lutenca and what is it used for
  3. What you need to know before you are given the radiolabeled medication with Lutenca
  4. How to use the radiolabeled medication with Lutenca
  5. Possible side effects
  6. Storage of Lutenca
  7. Package Contents and Additional Information

Introduction

Package Leaflet: Information for the Patient

Lutenca 40 GBq/ml Radiopharmaceutical Precursor in Solution

lutetium chloride (177Lu)

Read all of this leaflet carefully before you start receiving the combined medication with Lutenca, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your nuclear medicine doctor who will be supervising the procedure.
  • If you experience side effects, consult your nuclear medicine doctor. This includes any possible side effect not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Lutenca and what is it used for
  2. What you need to know before you are given the radiolabeled medication with Lutenca
  3. How to use the radiolabeled medication with Lutenca
  4. Possible side effects
  5. Storage of Lutenca
  6. Package Contents and Additional Information

1. What is Lutenca and what is it used for

Lutenca is not a final medication and should not be used alone. It must be used in combination with other medications (carrier medications).

Lutenca is a type of product called a radiopharmaceutical precursor. It contains the active ingredient lutetium chloride (177Lu) which emits beta radiation, allowing for localized radiation effects. This radiation is used to treat certain diseases.

Lutenca must be combined with a carrier medication in a process called radiolabeling before administration. The carrier medication then carries Lutenca to the site of the disease in the body.

These carrier medications have been specifically developed for use with lutetium chloride (177Lu) and may be substances designed to recognize a specific type of cell in the body.

Administration of radiolabeled medications with Lutenca involves exposure to radioactivity. Your doctor and nuclear medicine doctor have considered that the clinical benefit you will receive from the procedure with the radiopharmaceutical outweighs the risks of radiation.

Consult the package leaflet of the medication that will be radiolabeled with Lutenca.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given the radiolabeled medication with Lutenca

The radiolabeled medication with Lutenca must not be used

  • if you are allergic to lutetium chloride (177Lu) or any of the other components of this medication (listed in section 6),
  • if you are pregnant or think you may be pregnant.

Consult the package leaflet of the medication that will be radiolabeled with Lutenca for more information.

Warnings and Precautions

Lutenca must not be administered directly to patients.

Be careful with the radiolabeled medication with Lutenca:

  • if you have kidney failure or bone marrow disease.

Treatment with lutetium (177Lu) can cause the following side effects:

  • reduction in the number of red blood cells (anemia);
  • reduction in the number of platelets in the blood (thrombocytopenia), which are important for stopping bleeding,
  • reduction in the number of white blood cells (leukopenia, lymphopenia, or neutropenia), which are important for protecting the body against infections.

Most of these events are mild and transient. In some patients, a reduction in the number of all three types of blood cells (red blood cells, platelets, and white blood cells - pancytopenia) has been described, which requires discontinuation of treatment.

Because lutetium (177Lu) can sometimes affect your blood cells, your doctor will perform blood tests before starting treatment and at regular intervals during treatment. Talk to your doctor if you experience shortness of breath, bruising, nosebleeds, bleeding gums, or if you develop a fever.

During peptide receptor radionuclide therapy for neuroendocrine tumors, the kidneys excrete radiolabeled somatostatin analogs. Therefore, your doctor will perform a blood test to measure kidney function before starting treatment and during treatment.

Treatment with lutetium (177Lu) can cause changes in liver function. Your doctor will perform a blood test to monitor your liver function during treatment.

Radiolabeled medications with lutetium (177Lu) can be administered directly into a vein through a tube called a cannula. Leaks of liquid into the surrounding tissue (extravasation) have been reported. Talk to your doctor if you experience swelling or pain in the arm.

After neuroendocrine tumors are treated with lutetium (177Lu), patients may experience symptoms associated with the release of hormones from tumor cells, known as a carcinoid crisis. Inform your doctor if you feel dizzy or weak or experience flushing or diarrhea after treatment.

Treatment with lutetium (177Lu) can cause tumor lysis syndrome, due to the rapid destruction of tumor cells. This can cause abnormal blood test results, irregular heartbeats, kidney failure, or seizures within a week after treatment. Your doctor will perform blood tests to monitor for this syndrome. Inform your doctor if you have muscle cramps, muscle weakness, confusion, or difficulty breathing.

Consult the package leaflet of the medication that will be radiolabeled with Lutenca for additional warnings and precautions.

Children and Adolescents

Lutenca must not be used directly in children and adolescents under 18 years of age.

Other Medications and Radiolabeled Medications with Lutenca

Inform your nuclear medicine doctor if you are taking, have recently taken, or may need to take any other medication, as some medications may interfere with the procedure.

It is not known if lutetium chloride (177Lu) can interact with other medications, as no specific studies have been conducted.

Pregnancy and Breastfeeding

You must inform your nuclear medicine doctor before administration of radiolabeled medications with Lutenca if there is any possibility that you may be pregnant, if you have a delayed period, or if you are breastfeeding.

In case of doubt, it is important that you consult your nuclear medicine doctor who is supervising the procedure.

If you are pregnant

Radiolabeled medications with Lutenca must not be administered if you are pregnant.

If you are breastfeeding

You will be asked to interrupt breastfeeding.

Please consult your nuclear medicine doctor when you can resume breastfeeding.

Driving and Using Machines

Your ability to drive and use machines may be affected by the medication used in combination with Lutenca. Please read the package leaflet of the medication in question carefully.

3. How to use the radiolabeled medication with Lutenca

There are strict rules for the use, handling, and disposal of radiopharmaceuticals. Radiolabeled medications with Lutenca will be used in special controlled areas. This medication will only be handled and administered by trained and qualified personnel to use it safely. These individuals will take special care in the safe use of this medication and will inform you of their actions.

The nuclear medicine doctor supervising the procedure will decide the amount of radiolabeled medication with Lutenca to be used in your case. This will be the minimum amount necessary to achieve the desired effect, depending on the medication taken with Lutenca and its intended use.

Administration of the radiolabeled medication with Lutenca and performance of the procedure

Lutenca must only be used in combination with another medication (carrier medication) that has been specifically developed and authorized for combination with lutetium chloride (177Lu). Administration will depend on the type of carrier medication. Please read the package leaflet of that medication carefully.

Duration of the procedure

Your nuclear medicine doctor will inform you about the usual duration of the procedure.

After administration of the radiolabeled medication with Lutenca

Your nuclear medicine doctor will inform you if you need to take special precautions after receiving the radiolabeled medication with Lutenca. Consult your nuclear medicine doctor if you have any questions.

If you have been given too much radiolabeled medication with Lutenca

The nuclear medicine doctor will handle the radiolabeled medication with Lutenca under closely controlled conditions, so it is very unlikely that an overdose will occur. However, in case of overdose or accidental intravenous injection of the unmarked product, you will receive appropriate treatment to eliminate the radionuclide from the body.

If you have any further questions about the use of the radiolabeled medication with Lutenca, consult your nuclear medicine doctor who is supervising the procedure.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, the radiolabeled medication with Lutenca can cause side effects, although not everyone will experience them.

Dry mouth has been reported in patients with prostate cancer who received treatment with lutetium (177Lu) and this side effect has been transient.

Very common side effects (may affect more than 1 in 10 people):

  • reduction in blood cell count (platelets, red blood cells, or white blood cells)
  • nausea
  • vomiting

Side effects reported in patients treated for neuroendocrine tumors:

Very common (may affect more than 1 in 10 people):

  • mild and temporary hair loss

Common (may affect up to 1 in 10 people):

  • bone marrow cancer (myelodysplastic syndrome)
  • reduction in the number of white blood cells (neutropenia)

Uncommon (may affect up to 1 in 100 people):

  • bone marrow cancer (acute myeloid leukemia)

Frequency not known (cannot be estimated from the available data):

  • carcinoid crisis
  • tumor lysis syndrome (rapid destruction of tumor cells)
  • reduction in the number of red blood cells, platelets, and white blood cells (pancytopenia)
  • dry mouth

Cases of bone marrow cancer (myelodysplastic syndrome and acute myeloid leukemia) have been reported in patients several years after treatment with peptide receptor radionuclide therapy with lutetium (177Lu) for neuroendocrine tumors.

After administration of the radiolabeled medication with Lutenca, it will release a certain amount of ionizing radiation (radioactivity) which carries a risk of cancer and some congenital defects. In all cases, the risk of radiation is outweighed by the potential benefits of administering the radiolabeled medication.

If you want more information, consult the package leaflet of the specific medication that will be radiolabeled.

Reporting side effects

If you experience side effects, consult your nuclear medicine doctor, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Lutenca

You will not need to store this medication. The medication is stored under the responsibility of the specialist in suitable facilities. The storage of radiopharmaceuticals will be carried out in accordance with national regulations on radioactive materials.

The following information is intended only for the specialist:

Keep this medication out of the sight and reach of children.

Lutenca must not be used after the expiration date and time stated on the label

Lutenca will be stored in its original packaging, which provides protection against radiation.

This medication does not require any special storage temperature.

6. Package Contents and Additional Information

Composition of Lutenca

  • The active ingredient is lutetium chloride (177Lu).

1 ml of sterile solution contains 40 GBq of lutetium chloride (177Lu) at the calibration date and time, which corresponds to 10 micrograms of lutetium (177Lu) (in the form of chloride).

(GBq: The Gigabecquerel is the unit in which radioactivity is measured).

  • The other ingredient is hydrochloric acid, diluted.

Appearance of Lutenca and Package Contents

Lutenca is a radiopharmaceutical precursor in solution. It is presented as a clear and colorless solution in a 3 ml or 10 ml colorless glass vial with a bromobutyl stopper and sealed with an aluminum cap. Each package contains 1 vial, which is placed in a lead container for shielding.

The volume of a vial ranges from 0.025 - 5 ml of solution. The volume depends on the amount of medication combined with Lutenca necessary for administration by the nuclear medicine specialist.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Monrol Europe S.R.L

Str. Gradinarilor, nr.1, Pantelimon,

077145, Ilfov county,

Romania

Phone: +40 21 367 48 01

Fax: +40 21 311 75 84

Manufacturer

Monrol Bulgaria Ltd

Lulin District,

128 Bansko Shose Str.,

Sofia 1331, Bulgaria

Phone: + 359 2 824 12 13

Fax: +359 2 824 12 89

This medication is authorized in the Member States of the European Economic Area under the following names:

France: Lutenca

Italy: Lutenca

Portugal: Lutenca

Spain: Lutenca

Sweden: Lutenca

Date of last revision of this leaflet: October 2023

Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

This information is intended only for healthcare professionals:

The complete technical data sheet for Lutenca is included as a separate document in the product packaging, with the aim of providing healthcare professionals with additional scientific and practical information on the administration and use of this radiopharmaceutical.

Please consult this technical data sheet.

Online doctors for LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION

Discuss questions about LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor

Andreea Mateescu

Paediatrics8 years of experience

Dr Andreea Mateescu is a board-certified paediatrician with 7 years of clinical experience. She graduated from Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, and completed her paediatric residency at INSMC Alessandrescu-Rusescu. She also holds additional training in general ultrasound diagnostics.

Dr Mateescu focuses on providing high-quality, evidence-based medical care for children, with a strong emphasis on prevention, healthy development, and long-term wellbeing. She believes that clear, empathetic communication with both children and parents is essential for building trust and ensuring effective care.

Online consultations with Dr Mateescu are suitable for:

  • preventive check-ups and monitoring of growth and development;
  • vaccination planning, including personalised and catch-up schedules;
  • assessment of psychomotor, emotional, and physical development;
  • diagnosis and management of acute and chronic paediatric conditions;
  • nutritional guidance for infants and children, including formula selection when medically indicated;
  • care for children with complex or rare conditions;
  • practical guidance and ongoing support for parents.
Dr Mateescu works with patience, empathy, and professionalism, ensuring that each child receives attentive, individualised care. Her goal is to support healthy, balanced development while helping parents feel confident and well-informed at every stage of their child’s care.
Book a video appointment
€60
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56

Frequently Asked Questions

LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION is manufactured by Monrol Europe S.R.L.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, LUTENCA 40 GBq/mL RADIOPHARMACEUTICAL PRECURSOR IN SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance () include SODIUM IODIDE (I131) CURIUM PHARMA SPAIN 37-7400 MBq CAPSULES, LUTATHERA 370 MBq/mL SOLUTION FOR INFUSION, PLUVICTO 1000 MBq/mL Injectable Solution and Perfusion Solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media